Clinical trials: Signs and Symptoms, Digestive
Postoperative Nausea and Vomiting
Effect of Ramosetron on Bowel Motility After Gynecological Surgery
Ramosetron is effective in preventing postoperative nausea and vomiting. Several studies reported that ramosetron is also effective treatment of irritable bowel syndrome.
- Trial name
- NCT02849483
- Testing
- Ramosetron, Normal saline
- Where
- South Korea
- Volunteers
- 88 people
- Sponsor
- Kyunghee University Medical Center
Signs and Symptoms, Digestive, Dyspepsia
Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function
The purpose of this pilot study is to evaluate whether a probiotic supplement improves gastrointestinal (GI) function.
- Trial name
- NCT02928484
- Testing
- Probiotic mix CBP-004019/C
- Where
- Spain
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Biopolis S.L.
Signs and Symptoms, Digestive
Fiber Tolerability in Children Aged 3-7 Year
Determination of the digestive tolerability of the PROMITOR® in children from 3 to 7 years old.
- Trial name
- Fiber - TIC (NCT02677090)
- Testing
- Dose 1 - Promitor®, Dose 2 - Promitor®, Dose 3 - Promitor®
- Where
- France
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- Société des Produits Nestlé (SPN)
Gastrointestinal Lesions, Signs and Symptoms, Digestive
Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®
The purpose of this study is to learn more about symptoms and gastrointestinal lesions associated with taking myfortic® by switching patients to a delayed release formulation that is developed to alleviate GI symptoms.
- Trial name
- NCT00652834
- Testing
- Small bowel capsule endoscopy (SBCE), myfortic
- Where
- United States
- Volunteers
- 23 people
- Sponsor
- University of California, Los Angeles
Signs and Symptoms, Digestive
Fiber Tolerability in Children
Assessment of the digestive tolerability of the PROMITOR® .
- Trial name
- FITIC (NCT02519374)
- Testing
- PROMITOR® (including Maltodextrin)
- Where
- 2 sites in France, Switzerland
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Société des Produits Nestlé (SPN)
Signs and Symptoms, Digestive
Gastrointestinal Tolerability Following Multiple Servings of a Novel Dietary Fiber
The study will assess the gastrointestinal tolerability of multiple servings of a novel dietary fiber at three different dose levels in generally healthy men and women.
- Trial name
- NCT02532985
- Testing
- Negative Control, Positive Fiber Control, Novel Fiber
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Cargill
Signs and Symptoms, Digestive
Acute Gastrointestinal Tolerability Following a Single Serving of a Novel Dietary Fiber
The study will assess the gastrointestinal tolerability of a single serving of a novel dietary fiber at three different dose levels in generally healthy men and women.
- Trial name
- NCT02530762
- Testing
- Novel Fiber, Positive Fiber control, Negative Control
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Cargill
Hepatic Encephalopathy, HE
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
The purpose of this study is to evaluate whether the use of polyethylene glycol is superior and more safe in treating hepatic encephalopathy compared to lactulose and also to determine if treatment with polyethylene glycol will…
- Conditions
- Hepatic Encephalopathy, HE, Cirrhosis, Altered Mental Status
- Trial name
- HELP (NCT01923376)
- Testing
- Lactulose, Polyethylene Glycol 3350
- Where
- United States
- Sponsor
- New York Presbyterian Brooklyn Methodist Hospital
Dyspepsia, Functional Dyspepsia
A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia
To examine the safety and efficacy of Z-338 (YM443) after long-term administration in patients with functional dyspepsia, and also to examine the pattern of long-term administration.
- Trial name
- NCT00764374
- Testing
- YM443
- Where
- 4 sites in Japan
- Volunteers
- 412 people
- Sponsor
- Astellas Pharma Inc
Stress, Signs and Symptoms, Digestive
The Acute Effect of Coffee Consumption on Stomach, Self-reported Gastrointestinal Symptoms and Stress.
This study investigated the acute effect of the consumption of four different kinds of coffee (hot and cold instant coffee, cold espresso and hot filter coffee) with the same caffeine content on salivary gastrin, cortisol and…
- Conditions
- Stress, Signs and Symptoms, Digestive, Blood Pressure, Increased Secretion of Gastrin
- Trial name
- NCT02253628
- Testing
- Cold espresso, Hot instant coffee, Cold instant coffee
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Agricultural University of Athens
Gastroparesis, Diabetic Gastroparesis
Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis
The investigators hypothesize that in adult patients with diabetic gastroparesis with Type 1 diabetes (HbA1c ≤ 10.5%), daily tadalafil use will significantly improve gastric emptying compared to baseline as measured by gastric…
- Conditions
- Gastroparesis, Diabetic Gastroparesis, Nausea, Vomiting
- Trial name
- NCT01326117
- Testing
- tadalafil
- Where
- United States
- Sponsor
- Mark Feinglos
Dietary Modification, Dyslipidemia
Treatment With Nutritional Eating Plan and Dietary Fibers in Adult Patients With HIV/AIDS
To evaluate if nutritional treatment with nutritional supplementation of dietary fiber reduces cholesterol levels and triglycerides (dyslipidemia) in patients with HIV/AIDS receiving antiretroviral therapy (HAART).
- Conditions
- Dietary Modification, Dyslipidemia, Signs and Symptoms, Digestive, HIV
- Trial name
- PRECOR-NUT (NCT02180035)
- Testing
- Symbiotic, Nutritional intervention
- Where
- Brazil
- Volunteers
- 290 people
- Sponsor
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Signs and Symptoms, Digestive
Clinical Trial Evaluating the Viability of L. Casei + Fish Oil Capsules
The purpose of this study is to determine the effects of the probiotic KE-99 Lactobacillus casei when administered with omega-3 fish oil on probiotic viability, fecal make-up and gastrointestinal (GI) health in healthy adults.
- Trial name
- Probiomega (NCT01464814)
- Testing
- probiotic plus fish oil capsule, Fish oil capsule
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Nutrition 21, Inc.
Gastrointestinal Disease, Signs and Symptoms, Digestive
Nexium Dyspepsia/AST
The aim is to evaluate if the resolution of upper abdominal symptoms (pain or burning) during an acid suppressive test trial of esomprazole given daily for 7 days predicts symptoms resolution at the end of a subsequent treatment…
- Conditions
- Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia
- Trial name
- NCT00251914
- Testing
- Esomeprazole
- Where
- 215 sites in Argentina, Belgium and 15 more
- Volunteers
- 1,500 people
- Sponsor
- AstraZeneca
Gastrointestinal Disease, Signs and Symptoms, Digestive
Nexium Dyspepsia/AST
The aim is to evaluate if the resolution of upper abdominal symptoms (pain or burning) during an acid suppressive test trial of esomprazole given daily for 7 days predicts symptoms resolution at the end of a subsequent treatment…
- Conditions
- Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia
- Trial name
- NCT00251992
- Testing
- Esomeprazole
- Where
- 183 sites in Austria, Belgium and 11 more
- Volunteers
- 1,200 people
- Sponsor
- AstraZeneca
Signs and Symptoms, Digestive
Fermented Milk Drink on Human Intestinal Microflora
Fermented milk is a popular drink. Recent studies revealed that some fermented milk containing some strains of lactic acid bacteria have health-promoting effects through improvement of the intestinal microflora and modulation of…
- Trial name
- NCT00822328
- Testing
- Yakult®300, Lactobacillus casei strain Shirota
- Where
- Taiwan
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Cheng Hsin Rehabilitation Medical Center
Autism, Autistic Disorder
Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
The purpose of this study is to determine if human immunoglobulin given by mouth twice a day is effective in treating the persistent gastrointestinal (GI) problems such as diarrhea, constipation, abdominal pain, and bloating, in…
- Conditions
- Autism, Autistic Disorder, Child Development Disorders, Pervasive, Gastrointestinal Diseases
- Trial name
- NCT00110708
- Testing
- Oralgam (human immunoglobulin)
- Where
- 22 sites in United States
- Volunteers
- 120 people
- Sponsor
- PediaMed Pharmaceuticals